896 related articles for article (PubMed ID: 27825565)
1. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
2. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
3. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
4. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer.
Sachdeva M; Sachdeva N; Pal M; Gupta N; Khan IA; Majumdar M; Tiwari A
Cancer Gene Ther; 2015 Nov; 22(11):509-17. PubMed ID: 26494554
[TBL] [Abstract][Full Text] [Related]
6. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
7. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
8. CRISPR genome-editing: A medical revolution.
Butler JR; Tector AJ
J Thorac Cardiovasc Surg; 2017 Feb; 153(2):488-491. PubMed ID: 28104200
[No Abstract] [Full Text] [Related]
9. Plant genome engineering in full bloom.
Lozano-Juste J; Cutler SR
Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
[TBL] [Abstract][Full Text] [Related]
10. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
11. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
Maier LK; Marchfelder A; Randau L
Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
[No Abstract] [Full Text] [Related]
12. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
14. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
[TBL] [Abstract][Full Text] [Related]
15. Targeted Base Editing Systems Are Available for Plants.
Marzec M; Hensel G
Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
[TBL] [Abstract][Full Text] [Related]
16. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
[TBL] [Abstract][Full Text] [Related]
17. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
Zaidi SS; Mahfouz MM; Mansoor S
Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
[TBL] [Abstract][Full Text] [Related]
19. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.
Luo JJ; Bian WP; Liu Y; Huang HY; Yin Q; Yang XJ; Pei DS
FASEB J; 2018 Sep; 32(9):5132-5142. PubMed ID: 29812974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
